562
Participants
Start Date
June 30, 2014
Primary Completion Date
May 26, 2016
Study Completion Date
October 31, 2018
Trastuzumab
Trastuzumab 6mg/kg is ongoing to be administered for both arms after 8mg/kg loading dose.
Lima
Taipei
Kaohsiung City
Manila
Budapest
Quezon City
Buenos Aires
Makati
San Juan City
Pasig
City of Taguig
Johannesburg
Johannesburg
Arequipa
Debrecen
San Salvador de Jujuy
Cebu
Port Elizabeth
Santa Rosa
George
Cape Town
Cherkasy
Vinnytsia
Pavia
Khmelnytskyi
Piacenza
Poltava
Acapulco
Sumy
Taichung
Seville
Rimini
Zaragoza
Nancy
Kharkiv
Monterrey
Zaporizhzhia
Bari
Sarajevo
Kherson
Gdansk
Donetsk
Uzhhorod
Lodz
New Delhi
Delhi
Moscow
Moscow
Arkhangelsk
Saint Petersburg
Saint Petersburg
Saint Petersburg
Saint Petersburg
Minsk
Minsk
Brest
Obninsk
Jaipur
Kursk
Cluj-Napoca
Cluj-Napoca
Pune
Kazan'
Nashik
Nashik
Saransk
Samara
Brasov
Bangalore
Chennai
Chennai
Nizhny Novgorod
Novosibirsk
Krasnoyarsk
Kolkata
Suceava
Lisbon
Temuco
Santiago
Córdoba
Quilmes
Rosario
Tbilisi
Tbilisi
Tbilisi
Tbilisi
Tbilisi
Mumbai
Tokyo
Arequipa
Trujillo
Omsk
Daugavpils
Riga
Warsaw
Bucharest
Bucharest
Pretoria
Lead Sponsor
Collaborators (1)
Nippon Kayaku Co., Ltd.
INDUSTRY
Celltrion
INDUSTRY